FR3053252B1 - Produit, ou agent actif, ou composition pour le soin des seins en periode pre-mensuelle ou menstruelle ou pour le soin de la symptomatologie des mastodynies - Google Patents
Produit, ou agent actif, ou composition pour le soin des seins en periode pre-mensuelle ou menstruelle ou pour le soin de la symptomatologie des mastodynies Download PDFInfo
- Publication number
- FR3053252B1 FR3053252B1 FR1656119A FR1656119A FR3053252B1 FR 3053252 B1 FR3053252 B1 FR 3053252B1 FR 1656119 A FR1656119 A FR 1656119A FR 1656119 A FR1656119 A FR 1656119A FR 3053252 B1 FR3053252 B1 FR 3053252B1
- Authority
- FR
- France
- Prior art keywords
- care
- mastodynia
- symptomatology
- product
- active agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 206010006298 Breast pain Diseases 0.000 title abstract 3
- 208000006662 Mastodynia Diseases 0.000 title abstract 3
- 239000013543 active substance Substances 0.000 title abstract 3
- 210000000481 breast Anatomy 0.000 title abstract 3
- 230000003821 menstrual periods Effects 0.000 title 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 4
- -1 glycerol triesters Chemical class 0.000 abstract 2
- 150000002632 lipids Chemical class 0.000 abstract 2
- 230000002175 menstrual effect Effects 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 1
- 235000015112 vegetable and seed oil Nutrition 0.000 abstract 1
- 239000008158 vegetable oil Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C409/00—Peroxy compounds
- C07C409/02—Peroxy compounds the —O—O— group being bound between a carbon atom, not further substituted by oxygen atoms, and hydrogen, i.e. hydroperoxides
- C07C409/04—Peroxy compounds the —O—O— group being bound between a carbon atom, not further substituted by oxygen atoms, and hydrogen, i.e. hydroperoxides the carbon atom being acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/327—Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/25—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids with polyoxyalkylated alcohols, e.g. esters of polyethylene glycol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/795—Polymers containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/38—Percompounds, e.g. peracids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G75/00—Macromolecular compounds obtained by reactions forming a linkage containing sulfur with or without nitrogen, oxygen, or carbon in the main chain of the macromolecule
- C08G75/24—Polysulfonates
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
- C11C3/00—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
- C11C3/006—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by oxidation
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
- C11C3/00—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
- C11C3/04—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils
- C11C3/06—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils with glycerol
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Wood Science & Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Polymers & Plastics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
L'invention concerne un produit, ou agent actif, ou une composition. Ce produit, agent actif ou composition consiste essentiellement en des lipides peroxydés, par exemple des Triesters de Glycérol perOxydés (en abrégé TGO) ou comprenant des lipides peroxydés, par exemple des Triesters de Glycérol perOxydés (en abrégé TGO), en particulier sous forme d'une huile végétale peroxydée, pour le soin ou le traitement des seins lors de phases prémenstruelles ou menstruelles et aussi pour le soin ou le traitement de la symptomatologie des mastodynies. L'invention permet la mise en œuvre d'une méthode de soin ou de traitement des seins lors de phases prémenstruelles ou menstruelles et aussi le soin ou le traitement de la symptomatologie des mastodynies.
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1656119A FR3053252B1 (fr) | 2016-06-29 | 2016-06-29 | Produit, ou agent actif, ou composition pour le soin des seins en periode pre-mensuelle ou menstruelle ou pour le soin de la symptomatologie des mastodynies |
US15/631,188 US20180002281A1 (en) | 2016-06-29 | 2017-06-23 | Product, or active agent, or composition for the care of the breasts in a premenstrual or menstrual period or for the care of the symptomatology of mastodynia |
ES201730858A ES2657828B2 (es) | 2016-06-29 | 2017-06-28 | Producto, o agente activo, o composicion para el cuidado de los senos en periodo pre-menstrual o menstrual o para el cuidado de la sintomatologia de las mastodinias |
DE102017114413.7A DE102017114413A1 (de) | 2016-06-29 | 2017-06-28 | Produkt oder Wirkstoff oder Zusammensetzung zur Pflege der Brüste in der Zeit vor oder während der Menstruation oder zur Pflege der Symptomatologie von Mastodynien |
GB1710439.9A GB2556959A (en) | 2016-06-29 | 2017-06-29 | Product, or active agent, or composition for the care of the breasts in a premenstrual or menstrual period or for the care of menstrual period or for the care |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1656119A FR3053252B1 (fr) | 2016-06-29 | 2016-06-29 | Produit, ou agent actif, ou composition pour le soin des seins en periode pre-mensuelle ou menstruelle ou pour le soin de la symptomatologie des mastodynies |
FR1656119 | 2016-06-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
FR3053252A1 FR3053252A1 (fr) | 2018-01-05 |
FR3053252B1 true FR3053252B1 (fr) | 2020-04-24 |
Family
ID=56943727
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR1656119A Active FR3053252B1 (fr) | 2016-06-29 | 2016-06-29 | Produit, ou agent actif, ou composition pour le soin des seins en periode pre-mensuelle ou menstruelle ou pour le soin de la symptomatologie des mastodynies |
Country Status (5)
Country | Link |
---|---|
US (1) | US20180002281A1 (fr) |
DE (1) | DE102017114413A1 (fr) |
ES (1) | ES2657828B2 (fr) |
FR (1) | FR3053252B1 (fr) |
GB (1) | GB2556959A (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20210220423A1 (en) * | 2021-04-06 | 2021-07-22 | Earl Marek | Pain reliever composition |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ280017A (en) * | 1994-09-21 | 1997-06-24 | Scotia Holdings Plc | Use of n-6 or n-3 series essential fatty acid (efa), and optionally an oestrogen, to make a medicament to treat or prevent hormone replacement therapy (hrt) associated breast pain in peri- or postmenopausal women; medicaments containing the efa and estrogen. |
MY118354A (en) * | 1995-05-01 | 2004-10-30 | Scarista Ltd | 1,3-propane diol derivatives as bioactive compounds |
FR2793410B1 (fr) * | 1999-05-12 | 2004-10-29 | Carilene Lab | Utilisation de lipides peroxydes comme agents destines a prevenir et/ou a traiter les effets irritants d'un principe actif |
FR2797586B1 (fr) * | 1999-08-16 | 2001-11-09 | Stephane Desjonqueres | Utilisation de lipides peroxydes comme agents destines a former un film lipidique sur la peau |
US20040081672A1 (en) * | 2002-10-25 | 2004-04-29 | Gupta Shyam K. | Niacinamide, niacin, and niacin esters based delivery systems for treating topical disorders of skin and skin aging |
FR2848852B1 (fr) * | 2002-12-23 | 2007-03-16 | Carilene Lab | Composition huileuse a base de lipides peroxydes utilisable dans le traitement de la xerostomie |
US20090130048A1 (en) * | 2007-11-19 | 2009-05-21 | Oronsky Bryan Todd | Topical Composition for Treating Pain |
FR2929516A1 (fr) * | 2008-04-03 | 2009-10-09 | Carilene Lab | Composition dermatologique utilisable notamment pour le soin et la prevention des escarres |
WO2009155497A1 (fr) * | 2008-06-19 | 2009-12-23 | Lina Kennedy | Produit et composition destinés à soulager des symptômes post-menstruels comprenant du carapa procera et du calotropis procera |
FR2947178B1 (fr) * | 2009-06-29 | 2012-07-06 | Effik | Composition pharmaceutique a base de progesterone micronisee et ses utilisations |
FR2954701B1 (fr) * | 2009-12-24 | 2012-02-03 | Carilene Lab | Compositions dermatologiques contenant une association de lipides peroxydes et de zinc et leurs utilisations notamment dans le traitement de l'herpes |
US20130345316A1 (en) * | 2012-06-21 | 2013-12-26 | L'oreal | Water-releasing cosmetic composition |
-
2016
- 2016-06-29 FR FR1656119A patent/FR3053252B1/fr active Active
-
2017
- 2017-06-23 US US15/631,188 patent/US20180002281A1/en not_active Abandoned
- 2017-06-28 DE DE102017114413.7A patent/DE102017114413A1/de active Pending
- 2017-06-28 ES ES201730858A patent/ES2657828B2/es active Active
- 2017-06-29 GB GB1710439.9A patent/GB2556959A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
ES2657828A2 (es) | 2018-03-07 |
ES2657828R1 (es) | 2018-05-17 |
FR3053252A1 (fr) | 2018-01-05 |
GB2556959A (en) | 2018-06-13 |
DE102017114413A1 (de) | 2018-01-04 |
ES2657828B2 (es) | 2019-03-13 |
GB201710439D0 (en) | 2017-08-16 |
US20180002281A1 (en) | 2018-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12017502157A1 (en) | A process of refining glyceride oil comprising a basic ionic liquid treatment | |
CO2019004137A2 (es) | 1,2,4–triazolonas 2,4,5–trisustituidas | |
MA41060A (fr) | Compositions comprenant des souches bactériennes | |
MA55434A (fr) | Compositions comprenant des souches bactériennes | |
MA40755B1 (fr) | Compositions comprenant des souches bactériennes | |
MA41010A (fr) | Compositions comprenant des souches bactériennes | |
MX2019007587A (es) | Composicion oftalmica para el tratamiento de la enfermedad del ojo seco. | |
CR20210201A (es) | Nuevos compuestos antihelmínticos | |
PH12018500578A1 (en) | Methods of treating inflammatory diseases | |
TR201818825T4 (tr) | Kardi̇yak hi̇pertrofi̇ni̇n tedavi̇si̇ne ve tanisina yöneli̇k lncrnalar | |
MX2020001404A (es) | Dihidrooxadiazinonas. | |
MX2017013949A (es) | Composiciones mectantes a base de seda y sus metodos. | |
PH12020551796A1 (en) | Branched fatty acids and esters thereof | |
WO2015150449A3 (fr) | Composés azole amido-substitués | |
FR3029777B1 (fr) | Utilisation de l'association d'un polyether polyurethane non-ionique associatif et d'un derive de cyclohexanol comme agent rafraichissant de la peau | |
FR3053252B1 (fr) | Produit, ou agent actif, ou composition pour le soin des seins en periode pre-mensuelle ou menstruelle ou pour le soin de la symptomatologie des mastodynies | |
MX2018000847A (es) | Analogos metabolicamente robustos de cyp-eicosanoides para el tratamiento de enfermedades cardiacas. | |
MX2021005248A (es) | Anticuerpos contra cd73 activadores de células b. | |
MX2018007869A (es) | Composiciones para el cuidado personal. | |
EA201492238A1 (ru) | Композиция мизопростола | |
FR3065009B1 (fr) | Secretome bacterien pour son utilisation dans le traitement des lesions cutanees | |
FR3060307B1 (fr) | Composition cosmetique comprenant des corps gras solides et un polymere gelifiant | |
FR3078891B1 (fr) | Utilisation d’un extrait d’ilex aquifolium pour le traitement des desordres de la pigmentation et pour le blanchiment de la peau | |
EE201700038A (et) | Entomoloogilisi valke sisaldav preparaat ja meetod naistel esineva androgeenide defitsiidi ravimiseks | |
WO2017042577A8 (fr) | Nouvelle thérapie |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 2 |
|
PLSC | Publication of the preliminary search report |
Effective date: 20180105 |
|
PLFP | Fee payment |
Year of fee payment: 3 |
|
PLFP | Fee payment |
Year of fee payment: 4 |
|
PLFP | Fee payment |
Year of fee payment: 5 |
|
PLFP | Fee payment |
Year of fee payment: 6 |
|
PLFP | Fee payment |
Year of fee payment: 7 |
|
PLFP | Fee payment |
Year of fee payment: 8 |
|
TP | Transmission of property |
Owner name: LABORATOIRES CARILENE, FR Effective date: 20240201 |